TLSI: Innovative tumor drug delivery drives rapid growth, with new products and clinical data set to expand market share

The company is driving innovation in tumor drug delivery with a unique catheter technology, expanding rapidly in the liver embolization market, and targeting new indications. Financial performance is strong, with robust margins and a clear path to profitability, supported by upcoming product launch…